CAGR 5 peptide is supplied in a stable form, making it suitable for controlled laboratory applications where precision and purity are essential
Insulin can be injected into your upper legs (thighs), upper arms, or stomach area (abdomen)
Liver Research The glucagon receptor component makes retatrutide particularly active in liver research models
Consume Responsibly: Not recommended for children, people sensitive to caffeine, pregnant women or women who are nursing
The FDA still has specific criteria a substance must meet to be eligible for compounding, and the PCACs July 2026 review will determine whether any of these peptides will be officially cleared
Retatrutide refers to a peptide known as LY3437943, which acts on three receptors: the glucagon receptor (GCGR), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon-like peptide-1 receptor (GLP-1R)